Celltrion's YUFLYMA ® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths

[
Celltrion's YUFLYMA ® (adalimumab-aaty) receives FDA interchangeability designation for all its approved dosage forms and strengths
[og_img]
https://www.investing.com/news/press-releases/celltrions-yuflyma–adalimumabaaty-receives-fda-interchangeability-designation-for-all-its-approved-dosage-forms-and-strengths-93CH-4058539


Investing.com